A recent study indicates that patients who stop using popular slimming jabs like Wegovy and Mounjaro tend to recover reduced body mass at a significantly accelerated pace than those who end conventional lifestyle plans.
Published data in a leading health publication points out that while obese people frequently drop substantial amounts of their body weight while on the medication, the mass returns at an estimated rate of nearly a kilo each month once they quit.
"People using these medications should be informed of the risk of rapid rebound weight gain when the therapy concludes," stated lead investigator Dr. Susan Jebb.
Such speed of regain implies a return to pre-treatment mass in about a year and a half.
Analyzing Treatments
The research, which examined 37 of studies involving thousands of patients, compared the outcomes of these new drugs with older methods.
The team point out that individuals who shed pounds through diet and exercise usually experience a less rapid creep back—perhaps 100 grams monthly—post-intervention.
Explaining the Quick Regain
Doctors propose the way of the injections explains the amplified regain.
GLP-1 drugs imitate a body's own chemical called glucagon-like peptide-1, which helps regulate hunger.
"Long-term administration of GLP-1 levels far above than normal might result in the system to produce less of its endogenous hormone, and could lessen responsiveness to its actions," noted Dr. Adam Collins, a dietetics specialist.
"Stopping of this medication results in hunger is no longer kept in check, making overeating much more probable."
A Lifelong Issue?
Medical guidelines advise the jabs for people with weight-linked medical conditions, alongside recommended diet and exercise modifications.
Many experts argue that, due to the significant potential of relapse, the therapy should be considered long-term.
This perspective is echoed by drug manufacturers, who say that the results "underscore the chronic nature of excess weight," comparing it to managing diseases like high blood pressure.
User Testimonies
Users who have stopped the medication report a sudden return of hunger.
"It was like a switch activating and you become extremely hungry," recalled one woman.
This difficulty is compounded if individuals have not established sustainable dietary or behavioural modifications during treatment.
Significant Adoption
Survey data indicate that a significant number of adults in the UK have tried these injections in the last 12 months, with demand being substantial.
- Adoption is higher among females compared to males.
- The middle-aged age group shows the greatest usage rates.
- A large proportion obtain the medications through private prescriptions rather than the NHS.
In conclusion, researchers emphasize that while the jabs are effective tools for weight loss, they are not a magic fix and maintained weight loss hinges on integrated behavioural changes.
